An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Condition(s):Prostatic NeoplasmsLast Updated:December 13, 2023No longer available
Hide Studies Not Open or Pending
Condition(s):Prostatic NeoplasmsLast Updated:December 13, 2023No longer available
Condition(s):Prostate CancerLast Updated:September 16, 2020Completed
Condition(s):Prostatic NeoplasmsLast Updated:May 7, 2020Terminated
Condition(s):Prostate CancerLast Updated:June 11, 2014Terminated
Condition(s):Prostate CancerLast Updated:March 25, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:November 21, 2019Completed
Condition(s):Prostate CancerLast Updated:September 3, 2012Terminated
Condition(s):Prostate CancerLast Updated:April 9, 2014Terminated
Condition(s):Prostate CancerLast Updated:April 4, 2016Completed
Condition(s):Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate CancerLast Updated:December 12, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.